-
Consensus-Based Guidance for Bone Health Optimization in Spine Surgery
Sep 18, 2025, 18:38 PM -
Effect of ALK-TKI in ALK-Rearranged versus ALK-Rearranged With PD-L1 Positive NSCLC: A Target Trial Emulation Study
Sep 18, 2025, 18:38 PM -
Prediction of Rare Disease Medication Transition Patterns Based on an Interpretable Machine Learning Model
Sep 18, 2025, 18:38 PM -
Economic Evaluation of Neoadjuvant-Adjuvant Versus Adjuvant-Only Pembrolizumab in Resectable Melanoma
Sep 18, 2025, 18:38 PM -
Predicting Survival in Multiple Myeloma Patients With Diabetes Using Machine Learning: A 20-Year Cohort Study
Sep 18, 2025, 18:38 PM -
Artificial Intelligence Adoption in Clinical Practice in China: Patterns and Challenges
Sep 18, 2025, 18:38 PM -
Preferences for Adopting Artificial Intelligence in Radiation Therapy Treatment: A Discrete Choice Experiment
Sep 18, 2025, 18:38 PM -
Prevalence and Healthcare Resource Utilization Trend in Lung Cancer, Colorectal Cancer, Breast Cancer, and Prostate Cancer in Japan 2016–2024
Sep 18, 2025, 18:38 PM -
Impact of Child Maltreatment on Health-Related Quality of Life: Findings From the Australian Longitudinal Study on Women’s Health
Sep 18, 2025, 18:38 PM -
Comparative Efficacy and Safety of Sodium Picosulfate and Polyethylene Glycol in Chinese Population: A Meta-Analysis
Sep 18, 2025, 18:38 PM -
Leveraging Real-World Data (RWD) to Inform Drug Reimbursement in Asia-Pacific: Addressing Challenges and Building Solutions
Sep 18, 2025, 18:38 PM -
Real-World Uptake of SGLT2i Usage in Patients With Chronic Kidney Disease or Heart Failure: A German Claims Data Analysis
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Safety of Targeted NSCLC Therapies Using the FDA Adverse Event Reporting System (FAERS) Differing Experience of Healthcare Providers (HCP) From EU vs. US
Sep 9, 2025, 16:22 PM -
Systematic Review of Real-World Data on the Effectiveness and Safety Profiles of First-Line Therapies in Chronic Lymphocytic Leukemia
Sep 9, 2025, 16:22 PM -
Budgetary Impact of Generalized Pustular Psoriasis (GPP) in the Brazilian Private Healthcare System: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Economic Evaluation of the RESET Study Weight Loss Phase: Impact on Event Risk Reduction and Cost-Effectiveness in Type 2 Diabetes Management
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Censoring on Progression-Free Survival Comparisons of BCMA-Targeting Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 2 Diabetes Using Insulin in Sweden: A National Real-World Evidence Perspective
Sep 9, 2025, 16:22 PM -
Long-Term Impact of Emicizumab in Hemophilia A (HA): Analysis by Inhibitor Status in Three Latin American (LATAM) Countries
Sep 9, 2025, 16:22 PM -
Applying the Evidence-Generation Continuum Concept to Support Patient Access to Innovative Therapies in France: A Use Case in Rare Diseases
Sep 9, 2025, 16:22 PM
